Survival improvement in patients with pancreatic cancer by decade: A period analysis of the SEER database, 1981–2010
Open Access
- 23 October 2014
- journal article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 4 (1), 6747
- https://doi.org/10.1038/srep06747
Abstract
Pancreatic cancer (PaCa) is an aggressive malignancy with a high mortality rate and a poor prognosis. To evaluate treatment outcomes of patients with pancreatic cancer over the past three decades, data from the Surveillance, Epidemiology, and End Results (SEER) registries were used to assess the survival of patients with PaCa. A total of 63,530 patients diagnosed with pancreatic cancer between 1981 and 2010 were identified from nine original SEER registries. The 1-year relative survival rates (RSRs) improved each decade, from 17.0% to 19.9% to 28.2% (p < 0.0001), with a larger increase during the third decade than during the second decade. However, the long-term survival rates have remained very low. The 5-year RSRs increased from 3.1% to 4.4% to 6.9% over these three decades—i.e., still only few patients with PaCa survive more than 5 years. Furthermore, our analysis demonstrated that the survival rates for all the patients with pancreatic cancer were lower in patients of lower socioeconomic status and black race. These results will help predict future trends in PaCa incidence and survival, contribute to better-designed clinical trials by eliminating disparities that may affect the results, and thereby improve the clinical management and outcomes of PaCa.This publication has 26 references indexed in Scilit:
- Pancreatic cancer: A comprehensive review and updateDisease-a-Month, 2013
- Reproductive Factors, Exogenous Hormones, and Pancreatic Cancer Risk in the CTSAmerican Journal of Epidemiology, 2013
- Survival in Population-based Pancreatic Cancer Patients: San Francisco Bay Area, 1995-1999American Journal of Epidemiology, 2011
- Choosing the relative survival method for cancer survival estimationEuropean Journal of Cancer, 2011
- Vitamin D and Cancer Incidence in the Harvard CohortsAnnals of Epidemiology, 2009
- Neoadjuvant Radiation Is Associated With Improved Survival in Patients With Resectable Pancreatic Cancer: An Analysis of Data From the Surveillance, Epidemiology, and End Results (SEER) RegistryInternational Journal of Radiation Oncology*Biology*Physics, 2008
- Trends in the Treatment and Outcome of Pancreatic Cancer in the United StatesAnnals of Surgical Oncology, 2007
- Pancreatic Cancer in the General Population: Improvements in Survival Over the Last DecadeJournal of Gastrointestinal Surgery, 2006
- Race/Ethnicity, Gender, and Monitoring Socioeconomic Gradients in Health: A Comparison of Area-Based Socioeconomic Measures—The Public Health Disparities Geocoding ProjectAmerican Journal of Public Health, 2003
- Why Do Black Americans Have a Higher Risk of Pancreatic Cancer than White Americans?Epidemiology, 2003